Cargando…
What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889110/ https://www.ncbi.nlm.nih.gov/pubmed/35250956 http://dx.doi.org/10.3389/fmicb.2022.843587 |
| _version_ | 1784661325717176320 |
|---|---|
| author | Martinez, Miguel Angel |
| author_facet | Martinez, Miguel Angel |
| author_sort | Martinez, Miguel Angel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8889110 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88891102022-03-03 What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2? Martinez, Miguel Angel Front Microbiol Microbiology Frontiers Media S.A. 2022-02-16 /pmc/articles/PMC8889110/ /pubmed/35250956 http://dx.doi.org/10.3389/fmicb.2022.843587 Text en Copyright © 2022 Martinez. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Microbiology Martinez, Miguel Angel What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2? |
| title | What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2? |
| title_full | What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2? |
| title_fullStr | What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2? |
| title_full_unstemmed | What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2? |
| title_short | What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2? |
| title_sort | what should be learned from repurposed antivirals against sars-cov-2? |
| topic | Microbiology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889110/ https://www.ncbi.nlm.nih.gov/pubmed/35250956 http://dx.doi.org/10.3389/fmicb.2022.843587 |
| work_keys_str_mv | AT martinezmiguelangel whatshouldbelearnedfromrepurposedantiviralsagainstsarscov2 |